![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Celadon Pharmaceuticals Plc | LSE:CEL | London | Ordinary Share | GB00BDQYGP38 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
1.50 | 2.52% | 61.00 | 57.00 | 65.00 | 61.00 | 59.50 | 59.50 | 11,446 | 14:00:11 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Investment Advice | 149k | -7.14M | -0.1082 | -5.64 | 39.26M |
RNS Number:2482L Celsis International PLC 07 January 2008 TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES (1). Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: CELSIS INTERNATIONAL PLC 2. Reason for the notification (please state Yes/No): ( ) An acquisition or disposal of voting rights: X An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached: An event changing the breakdown of voting rights: Other (please specify) : 3. Full name of person(s) subject to the notification obligation: BARCLAYS GLOBAL INVESTORS 4. Full name of shareholder(s) (if different from 3.): BARCLAYS GLOBAL INVESTORS LTD 5. Date of the transaction and date on which the threshold is crossed or reached if different): 20-Dec-07 6. Date on which issuer notified: 24-Dec-07 7. Threshold(s) that is/are crossed or reached: 0% to 5% 8. Notified details: A: Voting rights attached to shares Class/type of shares Situation previous to if possible using the the Triggering ISIN CODE transaction Number of shares Number of voting Rights GB00B0CD5F69 0 0 Resulting situation after the triggering transaction Class/type of shares Number of shares Number of voting rights % of voting rights if possible using the ISIN CODE Direct Indirect Direct Indirect GB00B0CD5F69 1,190,770 0 1,190,770 0.00 5.39 B: Financial Instruments Resulting situation after the triggering transaction Type of Expiration Date Exercise/Conversion Number of voting % of voting financial Period/ Date rights that may be rights instrument acquired if the instrument is exercised/ converted. Total (A+B) Number of voting rights % of voting rights 1,190,770 5.39 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: BARCLAYS GLOBAL INVESTORS LTD Proxy Voting: 10. Name of the proxy holder: 11. Number of voting rights proxy holder will cease to hold: 12. Date on which proxy holder will cease to hold voting rights: 13. Additional information: 14. Contact name: GEOFF SMITH 15. Contact telephone number: 020 7116 2913 This information is provided by RNS The company news service from the London Stock Exchange END HOLUBRNRWKRARAR
1 Year Celadon Pharmaceuticals Chart |
1 Month Celadon Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions